Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Oct 15, 2020; 12(10): 1177-1194
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1177
Table 3 Multifactor analysis
VariableBSEWalddfSig.Exp(B)
Step 1
Differentiation4.17420.124
Differentiation (1)-0.8650.5902.14810.1430.421
Differentiation (2)-0.7630.4063.52810.0600.466
CEA classification0.0760.4340.03010.8611.079
Number of metastases-0.7580.4163.32310.0680.468
Size of metastases1.5160.39614.61610.0004.552
Proximity to great vessles-0.7940.4173.61610.0570.452
Liver treatment-0.0940.1740.28810.5910.911
Step 2
Differentiation4.17320.124
Differentiation (1)-0.8600.5892.13310.1440.423
Differentiation (2)-0.7490.3983.53210.0600.473
Number of metastases-0.7540.4143.31210.0690.471
Size of metastases1.5260.39215.19010.0004.599
Proximity to great vessles-0.7970.4173.65610.0560.451
Liver treatment-0.0970.1740.30810.5790.908
Step 3
Differentiation4.37320.112
Differentiation (1)-0.8390.5852.05710.1510.432
Differentiation (2)-0.7760.3963.83410.0500.460
Number of metastases-0.7950.4093.77810.0520.451
Size of metastases1.5830.37917.43810.0004.870
Proximity to great vessles-0.7930.4163.63910.0560.452
Step 4
Number of metastases-0.9100.4055.06510.0240.402
Size of metastases1.4900.36616.59610.0004.438
Proximity to great vessles-1.0010.3966.38410.0120.367
Differentiation1.3840.3927.23810.0080.507